Oligonucleotide Synthesis Services Market Growth Patterns And Forecast Outlook Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Oligonucleotide Synthesis Services Market From 2026 To 2030?

The oligonucleotide synthesis services market has experienced significant growth in recent years. It is anticipated to increase from $2.93 billion in 2025 to $3.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This historical expansion can be linked to the rise in PCR and sequencing applications, the broader scope of molecular biology research, an uptick in genomic testing, augmented academic genomics funding, and heightened biotechnology research and development endeavors.

The oligonucleotide synthesis services market is anticipated to experience robust expansion over the coming years. This market is projected to reach $4.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. Key factors driving this growth during the projected period include the expansion of gene and cell therapy pipelines, an increasing demand for CRISPR and gene editing technologies, the broadening application of nucleic acid therapeutics, greater utilization of precision diagnostics, and the scaling up of clinical oligonucleotide production. Noteworthy trends anticipated for the forecast period encompass high-throughput custom oligonucleotide manufacturing, services for modified and labeled oligonucleotides, GMP-grade oligo production, quick-turnaround gene editing oligonucleotides, and sophisticated oligo purification processes.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33245&type=smp

What Key Factors Are Affecting The Oligonucleotide Synthesis Services Market Demand?

The growing emphasis on personalized medicine is anticipated to fuel the expansion of the oligonucleotide synthesis services market in the future. Personalized medicine represents a healthcare strategy that tailors treatment and preventive measures according to an individual’s unique genetic, biological, and lifestyle traits. Its adoption is rising, driven by advancements in genomics and molecular diagnostics, enabling therapies to be specifically aligned with a patient’s genetic profile for improved results. Oligonucleotide synthesis services support personalized medicine by facilitating the quick and accurate creation of custom DNA or RNA sequences employed in patient-specific diagnostics, focused therapies, and gene-based treatments, thereby enabling interventions precisely matched to a person’s genetic makeup. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Among these newly approved personalized treatments for 2023 were also seven cancer medications and three for other illnesses and conditions. Consequently, the heightened focus on personalized medicine is a key factor propelling the growth of the oligonucleotide synthesis services market.

Which Segment Classifications Are Used In The Oligonucleotide Synthesis Services Market Segment Analysis?

The oligonucleotide synthesis services market covered in this report is segmented –

1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides

2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis

3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures

4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development

5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories

Subsegments:

1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides

2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides

3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids

4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2′-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids

5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers

What Trends Are Influencing Changes In The Oligonucleotide Synthesis Services Market?

Leading firms within the oligonucleotide synthesis services market are prioritizing the advancement of DNA and RNA production capacities, aiming to bolster therapeutic and diagnostic investigations. Such capabilities encompass sophisticated techniques for generating and expanding premium genetic material, which are essential for advancing research, diagnostics, and the creation of biopharmaceutical treatments. A notable example is Oligo Factory Inc., a US-based manufacturing company, which in May 2025 unveiled a low-scale oligo synthesis capability designed to extend assistance to therapeutic and diagnostic researchers and developers. This innovation facilitates custom DNA/RNA production in small batches, starting from 50 nmol, suitable for initial research and development phases across therapeutics, diagnostics, qPCR, NGS, and preclinical trials. It also helps reduce expenses and minimize waste, offers prompt delivery (in 4 weeks or less) meeting GMP or ISO 13485 quality standards, and ensures smooth scalability through portfolios like FactorTx, eliminating the need for vendor transitions. This adaptable approach proves beneficial for researchers who require prototypes rather than large minimum quantities.

Which Firms Are Contributing To The Oligonucleotide Synthesis Services Market Ecosystem?

Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.

Get The Full Oligonucleotide Synthesis Services Market Report:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-services-market-report

Where Is The Oligonucleotide Synthesis Services Market Most Concentrated Geographically?

North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oligonucleotide Synthesis Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=33245&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Services Market 2026, By The Business Research Company

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795